BMJ Nutrition, Prevention & Health ()

Temporal variations in the severity of COVID-19 illness by race and ethnicity

  • Brian Claggett,
  • Jane C Figueiredo,
  • Min Wu,
  • Hongwei Ji,
  • Nancy Sun,
  • Susan Cheng,
  • Patrick Botting,
  • Joseph E Ebinger,
  • Matthew Driver,
  • Eric Luong,
  • Elizabeth H Kim,
  • Amy Hoang,
  • Trevor Trung Nguyen,
  • Jacqueline Diaz,
  • Eunice Park,
  • Tod Davis,
  • Shehnaz Hussain

DOI
https://doi.org/10.1136/bmjnph-2021-000253

Abstract

Read online

Introduction Early reports highlighted racial/ethnic disparities in the severity of COVID-19 seen across the USA; the extent to which these disparities have persisted over time remains unclear. Our research objective was to understand temporal trends in racial/ethnic variation in severity of COVID-19 illness presenting over time.Methods We conducted a retrospective cohort analysis using longitudinal data from Cedars-Sinai Medical Center, a high-volume health system in Southern California. We studied patients admitted to the hospital with COVID-19 illness from 4 March 2020 through 5 December 2020. Our primary outcome was COVID-19 severity of illness among hospitalised patients, assessed by racial/ethnic group status. We defined overall illness severity as an ordinal outcome: hospitalisation but no intensive care unit (ICU) admission; admission to the ICU but no intubation; and intubation or death.Results A total of 1584 patients with COVID-19 with available demographic and clinical data were included. Hispanic/Latinx compared with non-Hispanic white patients had higher odds of experiencing more severe illness among hospitalised patients (OR 2.28, 95% CI 1.62 to 3.22) and this disparity persisted over time. During the initial 2 months of the pandemic, non-Hispanic blacks were more likely to suffer severe illness than non-Hispanic whites (OR 2.02, 95% CI 1.07 to 3.78); this disparity improved by May, only to return later in the pandemic.Conclusion In our patient sample, the severity of observed COVID-19 illness declined steadily over time, but these clinical improvements were not seen evenly across racial/ethnic groups; greater illness severity continues to be experienced among Hispanic/Latinx patients.